Oorsprong van het eerstegraads netwerk van Alexandre Jouve
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
ANTIGON SA
ANTIGON SA Medical SpecialtiesHealth Technology Antigon SA develops, manufactures, and supplies blood safety transfusion devices. The company is based in Charleroi, Belgium. Antigon was founded in 2016 by Francis Corazza, Hanane El Kenz, and Thierry Baltus.
5
| Holding Company | Medical Specialties | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Alexandre Jouve via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Innovation Fund (BE)
Innovation Fund (BE) Investment ManagersFinance Innovation Fund is a venture capital firm founded in 2015. The firm headquartered located in Schaerbeek, Belgium. | Investment Managers | Private Equity Investor | |
Université Paris-Saclay | College/University | Undergraduate Degree | |
Brussels South Charleroi BioPark Dev SA | Director/Board Member | ||
Spentys SA
Spentys SA Medical SpecialtiesHealth Technology Spentys SA is a Belgian company that offers a new way of creating personalized orthopedic immobilization devices. The company is based in Brussels, Belgium. The company provides a platform for patients to request a trial and access their knowledge articles for orthopedic professionals. Spentys was founded by Maxime Pierre Fabien Pignon, Louis-Philippe F. S. Broze, and Florian Laurent Joel de Boeck, with Louis-Philippe F. S. Broze serving as the CEO since incorporation. | Medical Specialties | Director/Board Member | |
Lys Medical SRL
Lys Medical SRL Miscellaneous Commercial ServicesCommercial Services Lys Medical SPRL engages in researching and developing biotechnology. The company was founded by Alain Richard Jules Delchambre, Benjamin Thomas Mertens and Jacques Maurice Devière on January 18, 2018 and is headquartered in Charleroi, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Inhatarget Therapeutics
Inhatarget Therapeutics Pharmaceuticals: MajorHealth Technology Inhatarget Therapeutics is a Belgian company that is developing targeted inhalation formulations to improve treatment for severe respiratory diseases, with a first focus on lung cancer. The company is based in Brussels, Belgium. The company is currently conducting clinical trials in 5 hospitals. The company's main objective is to create an inhaled chemotherapy for the treatment of lung cancer. | Pharmaceuticals: Major | Director/Board Member | |
ConvEyXo SA | Director/Board Member | ||
Theodorus Investment Funds
Theodorus Investment Funds Investment ManagersFinance Theodorus Investment Funds is a venture capital firm founded in 2003. The firm headquartered in Brussels, Belgium. | Investment Managers | Private Equity Investor | |
Solvay Business School of Economics & Management | College/University | Graduate Degree | |
Tools4patient SA
Tools4patient SA Packaged SoftwareTechnology Services Tools4patient SA develops and commercializes clinical development analytical tools for pharmaceutical and biotechnology companies. The company is based in Jumet, Belgium. The Belgian company was founded in 2013 by Denis Marcel Lucien Gossen, E. Iglesias Alvaro Pereira, Chantal Anne Ghislaine Cuvelier, Dominique Marcelle Renee Demolle, Jean-Marie Dethy, Chantal Christine Claudine Joelle Gossuin. Dominique Marcelle Renee Demolle has been the CEO since 2013. | Packaged Software | Director/Board Member | |
Sambrinvest SA
Sambrinvest SA Investment ManagersFinance Sambrinvest SA is a venture capital firm founded in 1985. Sambrinvest SA is headquartered in Gosselies, Belgium. | Investment Managers | Private Equity Investor | |
Omya Clariana SA
Omya Clariana SA Chemicals: SpecialtyProcess Industries Omya Clariana SA is calcium carbonate manufacturing company. It is engaged in the producing, import, export, marketing and distribution of calcium carbonate and it's raw materials, basic or processed products. The company was founded on March 3, 1969 and is headquartered in Belchite, Spain. | Chemicals: Specialty | Director/Board Member | |
Eli Lilly Benelux SA
Eli Lilly Benelux SA Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Benelux SA is a pharmaceutical company based in Brussels, Belgium. The Belgian company focuses on research and development to discover and offer innovative medicines that improve the quality of life for people worldwide. Lilly has established policies, standards, and protective measures for the entire research and development process to ensure that the patient remains the top priority. The CEO of the company is Frederic Clais. | Pharmaceuticals: Major | Sales & Marketing | |
Prométhéa Asbl | Director/Board Member | ||
Lundbeck SA
Lundbeck SA Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck SA is a Belgian company founded in 2000. The company is based in Brussels, Belgium. The company's description mentions that a migraine attack is a severe headache, usually present with other symptoms, that stops a person from going about their daily life. | Pharmaceuticals: Major | Chief Executive Officer | |
Harvard Business School | College/University | Masters Business Admin | |
ESSEC Business School | College/University | Graduate Degree |
Statistieken
Internationaal
België | 16 |
Frankrijk | 3 |
Spanje | 2 |
Verenigde Staten | 2 |
Sectoraal
Health Technology | 6 |
Consumer Services | 5 |
Finance | 4 |
Commercial Services | 2 |
Technology Services | 2 |
Operationeel
Director/Board Member | 14 |
Chief Executive Officer | 3 |
Founder | 3 |
Private Equity Investor | 3 |
Graduate Degree | 2 |
Sterkste connecties
Insiders | |
---|---|
Helena Pozios | 13 |
Thomas Lienard | 7 |
Terry Moro | 2 |
Thierry Baltus | 1 |
Hanane El Kenz | 1 |
- Beurs
- Insiders
- Alexandre Jouve
- Bedrijfsconnecties